These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19843073)

  • 1. LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells.
    Liu X; Xiong F; Wei X; Yang H; Zhou R
    Cancer Sci; 2009 Dec; 100(12):2335-40. PubMed ID: 19843073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line.
    Li L; Shan Y; Yang H; Zhang S; Lin M; Zhu P; Chen XY; Yi J; McNutt MA; Shao GZ; Zhou RL
    Anat Rec (Hoboken); 2011 Jul; 294(7):1135-42. PubMed ID: 21618708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
    Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R
    Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.
    Liu XR; Zhou RL; Zhang QY; Zhang Y; Jin YY; Lin M; Rui JA; Ye DX
    World J Gastroenterol; 2004 Jun; 10(11):1555-9. PubMed ID: 15162524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of lysosome-associated protein transmembrane-4β gene overexpression with the malignant phenotypes of hepatocellular carcinoma.
    Su H; Xu T; Huang X; Zang S; Wang B; Huang Y; Liu J; Huang A
    Pathol Res Pract; 2017 Dec; 213(12):1536-1541. PubMed ID: 29108920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity.
    Meng Y; Wang L; Xu J; Zhang Q
    Mol Oncol; 2018 Mar; 12(3):373-390. PubMed ID: 29337428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
    Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of lysosome-associated protein transmembrane 4B-35 in cancer and its correlation with the differentiation status of hepatocellular carcinoma.
    Peng C; Zhou RL; Shao GZ; Rui JA; Wang SB; Lin M; Zhang S; Gao ZF
    World J Gastroenterol; 2005 May; 11(18):2704-8. PubMed ID: 15884107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma.
    Shao GZ; Zhou RL; Zhang QY; Zhang Y; Liu JJ; Rui JA; Wei X; Ye DX
    Oncogene; 2003 Aug; 22(32):5060-9. PubMed ID: 12902989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma.
    Roy G; Roy P; Bhattacharjee A; Shahid M; Misbah M; Gupta S; Husain M
    Int J Biol Markers; 2018 Aug; 33(3):283-292. PubMed ID: 29882487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
    Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
    J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients.
    Yang H; Lin M; Xiong F; Yang Y; Nie X; McNutt MA; Zhou R
    Surg Today; 2011 Jun; 41(6):810-7. PubMed ID: 21626328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis.
    Li M; Zhou R; Shan Y; Li L; Wang L; Liu G
    Oncotarget; 2016 Sep; 7(36):58531-58542. PubMed ID: 27542271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
    Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
    Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling.
    Li L; Wei XH; Pan YP; Li HC; Yang H; He QH; Pang Y; Shan Y; Xiong FX; Shao GZ; Zhou RL
    Oncogene; 2010 Oct; 29(43):5785-95. PubMed ID: 20711237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells].
    He J; Shao G; Zhou R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):348-52. PubMed ID: 12947546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAPTM4B promotes the progression of nasopharyngeal cancer.
    Su Q; Luo H; Zhang M; Gao L; Zhao F
    Bosn J Basic Med Sci; 2021 Jun; 21(3):305-312. PubMed ID: 32651973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentivirus-mediated RNA Interference Targeting LAPTM4B Inhibits Human Ovarian Cancer Cell Invasion In Vitro.
    Meng F; Chen X; Song H; Lou G; Fu S
    Chem Biol Drug Des; 2016 Jan; 87(1):121-30. PubMed ID: 26247403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
    Wang L; Meng Y; Zhang QY
    BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LAPTM4B: an oncogene in various solid tumors and its functions.
    Meng Y; Wang L; Chen D; Chang Y; Zhang M; Xu JJ; Zhou R; Zhang QY
    Oncogene; 2016 Dec; 35(50):6359-6365. PubMed ID: 27212036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.